Used as a stable isotope-labeled internal standard in mass spectrometry-based bioanalytical studies to accurately quantify carazolol levels in biological samples. Its primary application is in pharmacokinetic and metabolism research, where it helps distinguish endogenous compounds from administered drugs due to its identical chemical behavior but distinct mass. Commonly employed in studies involving beta-blockers, particularly for validating analytical methods in drug development and therapeutic drug monitoring.